๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The Phase II Trial Of Erlotinib And Radiotherapy Following Chemoradiotherapy For Patients With Stage III Non-small Cell Lung Cancer Has Shown A Favorable Response Profile

โœ Scribed by Komaki, R.U.; Blumenschein, G.R.; Wistuba, I.I.; Lee, J.; Allen, P.K.; Wei, X.; Welsh, J.; O'Reilly, M.S.; Tang, X.; Hong, W.


Book ID
123381529
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
54 KB
Volume
81
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES